Vitamin D3 encapsulated in polymeric nanoparticles to dampen the pro-inflammatory immune response.
Ontology highlight
ABSTRACT: 1α25-dihydroxyvitamin D3, the active metabolite of vitamin D3 (VD3), is a modulator of inflammation well-known for its ability to promote anti-inflammatory and tolerogenic immune responses. It is therefore an attractive agent for the attenuation of inflammatory responses and the development of tolerogenic immunity in autoimmune diseases. To overcome VD3 toxicity and enhance its in vivo performance, nanoparticles (NPs) have emerged as a promising delivery platform. Therefore, in this study, we have developed VD3-loaded polymeric nanoparticles (VD3-NPs) as a therapeutical strategy for the treatment of autoimmune disorders. We demonstrate that VD3-NPs could successfully be generated and that they significantly inhibit secretion of IL-6, IL-10, IL-23, and TNFα in human whole blood cultu
SUBMITTER: Minnee J
PROVIDER: S-EPMC12529509 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA